| 157.19 0.45 (0.29%) | 01-14 11:20 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 187.56 | 1-year : | 219.08 |
| Resists | First : | 160.58 | Second : | 187.56 |
| Pivot price | 156.51  |
|||
| Supports | First : | 153.95 | Second : | 149.85 |
| MAs | MA(5) : | 157.26  |
MA(20) : | 155.98 |
| MA(100) : | 147.03 |
MA(250) : | 141.96 |
|
| MACD | MACD : | 1.1 |
Signal : | 1.2 |
| %K %D | K(14,3) : | 52.5 |
D(3) : | 56 |
| RSI | RSI(14): 55.7 |
|||
| 52-week | High : | 160.58 | Low : | 127.34 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ XLV ] has closed below upper band by 44.8%. Bollinger Bands are 32% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 157.87 - 158.64 | 158.64 - 159.39 |
| Low: | 153.45 - 154.43 | 154.43 - 155.39 |
| Close: | 154.93 - 156.48 | 156.48 - 158 |
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Wed, 14 Jan 2026
Leading And Lagging Sectors For January 14, 2026 - Benzinga
Mon, 12 Jan 2026
Leading And Lagging Sectors For January 12, 2026 - Benzinga
Fri, 09 Jan 2026
Betting on a Boom: 3 Healthcare ETFs for 2026 and Beyond - TradingView — Track All Markets
Fri, 09 Jan 2026
Palmetto Grain Brokerage - - Palmetto Grain Brokerage
Thu, 08 Jan 2026
3 Top ETFs To Profit As Investors Move Away From Big Tech in 2026 - 24/7 Wall St.
Fri, 02 Jan 2026
Spotlight on Health ETFs as NVO & LLY Cut Obesity Drug Price in China - Zacks Investment Research
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|